Suppr超能文献

结核分枝杆菌“穿戴”其所食。

Mycobacterium tuberculosis wears what it eats.

机构信息

Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.

出版信息

Cell Host Microbe. 2010 Jul 22;8(1):68-76. doi: 10.1016/j.chom.2010.06.002.

Abstract

Mycobacterium tuberculosis remains one of the most pernicious of human pathogens. Current vaccines are ineffective, and drugs, although efficacious, require prolonged treatment with constant medical oversight. Overcoming these problems requires a greater appreciation of M. tuberculosis in the context of its host. Upon infection of either macrophages in culture or animal models, the bacterium realigns its metabolism in response to the new environments it encounters. Understanding these environments, and the stresses that they place on M. tuberculosis, should provide insights invaluable for the development of new chemo- and immunotherapeutic strategies.

摘要

结核分枝杆菌仍然是最具危害性的人类病原体之一。目前的疫苗效果不佳,而药物虽然有效,但需要在持续的医疗监督下进行长期治疗。要克服这些问题,就需要在宿主背景下更深入地了解结核分枝杆菌。结核分枝杆菌感染培养的巨噬细胞或动物模型后,会根据其所处的新环境重新调整其代谢。了解这些环境以及它们给结核分枝杆菌带来的压力,应该为开发新的化学和免疫治疗策略提供宝贵的见解。

相似文献

1
Mycobacterium tuberculosis wears what it eats.结核分枝杆菌“穿戴”其所食。
Cell Host Microbe. 2010 Jul 22;8(1):68-76. doi: 10.1016/j.chom.2010.06.002.
4
Pathogen roid rage: cholesterol utilization by Mycobacterium tuberculosis.病原体的类固醇狂热:结核分枝杆菌对胆固醇的利用
Crit Rev Biochem Mol Biol. 2014 Jul-Aug;49(4):269-93. doi: 10.3109/10409238.2014.895700. Epub 2014 Mar 10.

引用本文的文献

10
Advances in the design of combination therapies for the treatment of tuberculosis.结核病治疗联合疗法设计的新进展。
Expert Opin Drug Discov. 2023 Jan;18(1):83-97. doi: 10.1080/17460441.2023.2157811. Epub 2022 Dec 28.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验